These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38277021)

  • 21. Recurrent pericarditis: new and emerging therapeutic options.
    Imazio M; Lazaros G; Brucato A; Gaita F
    Nat Rev Cardiol; 2016 Feb; 13(2):99-105. PubMed ID: 26259934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis.
    Wohlford GF; Buckley LF; Vecchié A; Kadariya D; Markley R; Trankle CR; Chiabrando JG; de Chazal HM; Van Tassell B; Abbate A
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):50-52. PubMed ID: 32398478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience.
    Ugurlu S; Ergezen B; Egeli BH; Selvi O; Ozdogan H
    Rheumatology (Oxford); 2021 May; 60(5):2327-2332. PubMed ID: 33295622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anakinra: an emerging option for refractory idiopathic recurrent pericarditis: a systematic review of published evidence.
    Lazaros G; Imazio M; Brucato A; Vassilopoulos D; Vasileiou P; Gattorno M; Tousoulis D; Martini A
    J Cardiovasc Med (Hagerstown); 2016 Apr; 17(4):256-62. PubMed ID: 26090915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra).
    Vassilopoulos D; Lazaros G; Tsioufis C; Vasileiou P; Stefanadis C; Pectasides D
    Int J Cardiol; 2012 Sep; 160(1):66-8. PubMed ID: 22704870
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anti-interleukin-1 agents: a new class of drugs for recurrent pericarditis. A practical guide for cardiologists].
    Imazio M; Lazaros G; Gattorno M; Abbate A; Brucato A
    G Ital Cardiol (Rome); 2021 Oct; 22(10):833-843. PubMed ID: 34570117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Adults with Idiopathic Recurrent Pericarditis: Novel Use of Immunotherapy.
    Schwier NC; Hale GM; Davies ML
    Pharmacotherapy; 2017 Mar; 37(3):305-318. PubMed ID: 28079270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Anakinra in steroid dependent recurrent pericarditis: a case report and review of literature.
    Thallapally VK; Gupta S; Gundepalli SG; Nahas J
    J Community Hosp Intern Med Perspect; 2021; 11(4):543-546. PubMed ID: 34262672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case series and systematic literature review of anakinra and immunosuppression in idiopathic recurrent pericarditis.
    Scott IC; Hajela V; Hawkins PN; Lachmann HJ
    J Cardiol Cases; 2011 Oct; 4(2):e93-e97. PubMed ID: 30534275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anakinra in Recurrent Pericarditis: Current Evidence on Clinical Use, Effectiveness, and Safety.
    Correia ETO; Dos Santos Barbetta LM; de Almeida JPCL; Mesquita ET
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):42-49. PubMed ID: 32265370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis.
    Andreis A; Imazio M; Giustetto C; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1561-1565. PubMed ID: 32868281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.
    Tomelleri A; Cavalli G; De Luca G; Campochiaro C; D'Aliberti T; Tresoldi M; Dagna L
    Front Immunol; 2018; 9():1233. PubMed ID: 29910817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of Interleukin-1 Receptor Antagonists in Patients With Recurrent Pericarditis.
    Khayata M; Shah NP; Verma BR; Giugni AS; Alkharabsheh S; Asher CR; Imazio M; Klein AL
    Am J Cardiol; 2020 Jul; 127():184-190. PubMed ID: 32416963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent pericarditis in children and adolescents: a multicentre cohort study.
    Imazio M; Brucato A; Pluymaekers N; Breda L; Calabri G; Cantarini L; Cimaz R; Colimodio F; Corona F; Cumetti D; Cuccio CD; Gattorno M; Insalaco A; Limongelli G; Russo MG; Valenti A; Finkelstein Y; Martini A
    J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):707-12. PubMed ID: 27467459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anakinra for colchicine refractory familial Mediterranean fever: a cohort of 44 patients.
    Marko L; Shemer A; Lidar M; Grossman C; Druyan A; Livneh A; Kivity S
    Rheumatology (Oxford); 2021 Jun; 60(6):2878-2883. PubMed ID: 34144604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology.
    Harrison SR; McGonagle D; Nizam S; Jarrett S; van der Hilst J; McDermott MF; Savic S
    JCI Insight; 2016 May; 1(6):e86336. PubMed ID: 27699261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anakinra as rescue therapy for steroid-dependent idiopathic recurrent pericarditis in children: case report and literature review.
    Rodriguez-Gonzalez M; Ruiz-Gonzalez E; Castellano-Martinez A
    Cardiol Young; 2019 Feb; 29(2):241-243. PubMed ID: 30511600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
    Ozen S; Bilginer Y; Aktay Ayaz N; Calguneri M
    J Rheumatol; 2011 Mar; 38(3):516-8. PubMed ID: 21159830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAPA Syndrome: Challenges in Achieving Long-Term Remission.
    Smajlović H; Prohić A
    Acta Dermatovenerol Croat; 2023 Nov; 31(2):106-109. PubMed ID: 38006373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pericarditis].
    Marques C; Cacoub P
    Rev Prat; 2021 Jan; 71(1):79-83. PubMed ID: 34160952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.